Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 ...

"Sanofi's collaboration with Exscientia aims to transform how we discover and develop new small molecule medicines for cancer and immune-mediated diseases," said the pharma group's chief ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.